Psychotropic deprescribing across different prescribing professions in New Mexico and Louisiana

This study aimed to assess differences in the rates of deprescribing between prescribing psychologists, psychiatrists, and primary care physicians. MarketScan private insurance claims were used to develop a longitudinal active-comparator, prevalent-user cohort of patients who were treated with a psychotropic medication from psychologists, psychiatrists, or primary care physicians for at least 90 days in New Mexico or Louisiana (states where psychologists can prescribe) between 2005-2021. The type of provider (psychologist, psychiatrist, or primary care physicians) who prescribed the psychotropic medication was the exposure of interest. Three measures of deprescribing were used as outcomes: deprescribing without replacement, complete discontinuation of prescribing, or a sustained reduction in the prescribed days' supply. Patient demographic and clinical characteristics during the six months prior to their initial prescription were measured as covariates. Inverse propensity of treatment weighting was used to adjust for baseline differences between provider groups, creating two weighted analytic cohorts with covariate balance: psychologists versus psychiatrists and psychologists versus primary care physicians. We estimated doubly-robust Cox Proportional Hazards models for each deprescribing measure in both cohorts. Prescribing psychologists deprescribed without replacement more than psychiatrists (Hazard ratio [95% CI] = 1.13 [1.06, 1.20]) and less than primary care physicians (0.73 [0.69, 0.78]). Conversely, they reduced the days' supply less often than psychiatrists (0.79 [0.69, 0.91]) and more than primary care physicians (1.64 [1.42, 1.90]). There were no differences in complete discontinuation between provider types. Prescribing psychologists deprescribe at a rate between psychiatrists and primary care physicians. Findings varied depending on the deprescribing measure used, suggesting psychotropic-specific deprescribing measures are needed.

Authors

Institutions

Publication Details

Journal
PLOS mental health.
Published
2025-12-30
DOI
https://doi.org/10.1371/journal.pmen.0000408
Primary Topic
Mental Health Treatment and Access
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Psychotropic deprescribing across different prescribing professions in New Mexico and Louisiana

Joshua D. Niznik, Robert E. McGrath, Robert B. Christian, Casey Tak et al.
PLOS mental health.
Mental Health Treatment and Access
article

Psychotropic deprescribing across different prescribing professions in New Mexico and Louisiana

Joshua D. Niznik, Robert E. McGrath, Robert B. Christian, Casey Tak, Betsy Sleath, Phillip M. Hughes, Kathleen C. Thomas
article en

Abstract

This study aimed to assess differences in the rates of deprescribing between prescribing psychologists, psychiatrists, and primary care physicians. MarketScan private insurance claims were used to develop a longitudinal active-comparator, prevalent-user cohort of patients who were treated with a psychotropic medication from psychologists, psychiatrists, or primary care physicians for at least 90 days in New Mexico or Louisiana (states where psychologists can prescribe) between 2005-2021. The type of provider (psychologist, psychiatrist, or primary care physicians) who prescribed the psychotropic medication was the exposure of interest. Three measures of deprescribing were used as outcomes: deprescribing without replacement, complete discontinuation of prescribing, or a sustained reduction in the prescribed days' supply. Patient demographic and clinical characteristics during the six months prior to their initial prescription were measured as covariates. Inverse propensity of treatment weighting was used to adjust for baseline differences between provider groups, creating two weighted analytic cohorts with covariate balance: psychologists versus psychiatrists and psychologists versus primary care physicians. We estimated doubly-robust Cox Proportional Hazards models for each deprescribing measure in both cohorts. Prescribing psychologists deprescribed without replacement more than psychiatrists (Hazard ratio [95% CI] = 1.13 [1.06, 1.20]) and less than primary care physicians (0.73 [0.69, 0.78]). Conversely, they reduced the days' supply less often than psychiatrists (0.79 [0.69, 0.91]) and more than primary care physicians (1.64 [1.42, 1.90]). There were no differences in complete discontinuation between provider types. Prescribing psychologists deprescribe at a rate between psychiatrists and primary care physicians. Findings varied depending on the deprescribing measure used, suggesting psychotropic-specific deprescribing measures are needed.

PLOS mental health.Vol. 2(12)
University of North Carolina at Chapel Hill (US), University of Utah (US), Fairleigh Dickinson University (US), VA Pittsburgh Healthcare System (US)
Openalex Percentile: Top 27%
Mental Health Treatment and Access
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.